Hygea VCT Discussion Board http://www.iii.co.uk/investment/detail?code=cotn:HYG.L&display=discussion http://www.iii.co.uk/icons/logos/uk_logo.gif http://www.iii.co.uk tag:iii.co.uk,2003:tst.9592313
They've promised they will look into paying 5p ongoing. By jonwig1 ]]> http://www.iii.co.uk/investment/detail?code=cotn:HYG.L&display=discussion&id=9592313&action=detail Mon, 30 Apr 2012 13:43:00 GMT jonwig1 tag:iii.co.uk,2003:tst.9592070 It would encourage a few people on board if they knew they were not missing the deadline- I definitely got the last one - and it was the biggest iv ever had !
I need this next one to of set the drop in share price like most other long term holders. By Papiv ]]> http://www.iii.co.uk/investment/detail?code=cotn:HYG.L&display=discussion&id=9592070&action=detail Mon, 30 Apr 2012 12:49:00 GMT Papiv tag:iii.co.uk,2003:tst.9515140
A 5p dividend would cost £400,000 compared with their current £300,000 cash in the bank.
There's also the question of further fundraisings from either SCLP or Immbio: a £1m would require of the order of £60,000 from HYG to avoid dilution.
To be fair to HYG, they do say in the results that they have some issues to resolve:

"It is also clear that it is difficult for a small fund to continue to support its investee companies and retain our stake without dilution and to date we believe we have been successful in balancing the needs of our investee companies with those of our shareholders. However we are currently exploring ways in which we might attract further funds into Hygea and we hope to be in a position to communicate these to shareholders later in the year."

SCLP seems to be benefitting from some of the hype which can be read over on that BB - I've no way of judging how realistic that is, but there's a chance HYG's sp will be carried along.

Hallmarq Vet is a pretty rich valuation, about £7.8m for the whole company based on sales of £2.7m and op pft of £188,000. Again, I don't know how reliable that is.

A really interesting one is Freehand 2010, which appears to have a total valuation of just £1.25m. Now judging by this link (Dec 2011) ...

http://www.stockopedia.co.uk/content/freehand-offers-investors-a-steady-view-of-surgery-innovation-62832/

... Freehand is being prepared for an AIM IPO this year. I doubt it would be worthwhile any company coming to AIM with such a low pro forma MCap, even 'blue sky' - and Freehand looks to be further advanced than that. Of course, if the IPO raised lots of new money, HYG would be diluted significantly, but there would still be a substantial uplift for its share.

("Weak buy" until some of the concerns are resolved.)

By jonwig1 ]]> http://www.iii.co.uk/investment/detail?code=cotn:HYG.L&display=discussion&id=9515140&action=detail Fri, 06 Apr 2012 11:23:00 GMT jonwig1 tag:iii.co.uk,2003:tst.9512030 http://www.iii.co.uk/investment/detail?code=cotn:HYG.L&display=discussion&id=9512030&action=detail Thu, 05 Apr 2012 12:43:00 GMT bonzoful tag:iii.co.uk,2003:tst.9511355
HYG have around 14.8m shares in SCLP, or around 7.6%. At the last Balance Sheet date of 31/12/11, HYG's holding of around 14.8m shares was only worth £0.89m. Now it's worth £2.3m at SCLP's current 15.5p.

HYG's NAV at 31/12/11 was 70.6p. SCLP has added another £1.4m of NAV, or around 17p per share based on HYG's 8.12m shares in issue.

Total NAV is therefore now around 88p per share - double the current 44p share price.

Each 1p added to SCLP's share price is worth roughly 2p onto HYG's NAV for reference.

HYG is pretty well run these days imo, perhaps better than in the past - their more recent investments are more sensible and less blue sky, keeping primarily to the medical equipment/diagnostics field, which can be pretty lucrative.

Most of their investments are maturing now from memory as they've held them for a while, so this is hopefully the stage that the "bottle-ageing" starts to reap rewards. DXS was a brilliant return for them and is still bringing in deferred consideration.

The NAV will also have been improved by the rise in EKF's and EHP's share prices since the year end.

SCLP is on a roll due to a tip from Galvan, and that roll may continue for a while yet.

If SCLP and/or another company becomes a winner then the £3.6m m/cap will look like peanuts. So as usual it all depends on whether investors have got the patience to hold tight etc etc......

The 34% holding in Freehand 2010 is also interesting. It ceased to be last year (can't remember whether administration/liquidation/whatever), but the HYG management basically rescued it themselves because they thought it was a great business (razor blade selling model etc). It's likely imo that HYG got 34% of this very cheaply, i.e in distressed circumstances. By gretel ]]> http://www.iii.co.uk/investment/detail?code=cotn:HYG.L&display=discussion&id=9511355&action=detail Thu, 05 Apr 2012 10:49:00 GMT gretel tag:iii.co.uk,2003:tst.7763818
TIDMHYG

For Immediate Release

9 February 2011

Hygea VCT plc

("Hygea" or "the Company")

Corporate Update

Hygea VCT has sent the following corporate update letter to its Shareholders today:

9 February 2011

Dear Shareholder,

Shareholder Update

Following our year end on 31st December 2010, I am writing to give Shareholders a brief update in advance of the publication of our audited results. We expect to announce our results at the beginning of April 2011 and have arranged for our Annual General Meeting to be held in London on Wednesday 11 May at noon.

Since the publication of our last Interim Management Statement, I am pleased to say that we have received further proceeds from our disposal of DxS amounting to ÂGBP223,405 reflecting DxS's achievement of milestones. We have now received ÂGBP554,605 since the original sale of our holding and expect further sums in due course.

However, during the period Freehand Surgical was placed into administration due to last minute difficulties in finding co-investment partners at an acceptable valuation. Our holding, which was last valued at ÂGBP687,753, will therefore be written off. We continue to believe that the prospects for the Freehand product, the rights to which have been purchased by Freehand 2010, remain very compelling and, therefore, since the year end, we have invested ÂGBP250,000 in Freehand 2010 which we expect will maintain our shareholding at around 10%.

In the last quarter of 2010 we have also subscribed ÂGBP200,000 in a new fundraising for Omega Diagnostics at 12p per share and have purchased 100,000 shares in Tristel plc for ÂGBP55,480.

In addition to our portfolio of unquoted companies, at the year end Hygea's unaudited accounts include quoted shares valued at a bid price of ÂGBP2,155,170 and cash of ÂGBP764,186.

Since the year end Hygea has subscribed ÂGBP72,340 into Archimed Limited, a wound care business which has been spun out of Insense.

Although the overall market conditions for medtech companies are tough, many of our investees are making good progress.

Yours sincerely,

James Otter.

Chairman.

END.

Enquiries:

Charles Breese, Hygea VCT plc on 01280 703482 orlarpentnewton@btinternet.com

Roland Cornish, Beaumont Cornish Limited on 020 7628 3396

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Hygea VCT plc via Thomson Reuters ONE

[HUG£1487129]

(END) Dow Jones Newswires

09-02-11 1214GMT
By SpikeyDT ]]> http://www.iii.co.uk/investment/detail?code=cotn:HYG.L&display=discussion&id=7763818&action=detail Wed, 09 Feb 2011 11:15:00 GMT SpikeyDT tag:iii.co.uk,2003:tst.5221596
G By Greyster ]]> http://www.iii.co.uk/investment/detail?code=cotn:HYG.L&display=discussion&id=5221596&action=detail Wed, 26 Aug 2009 08:58:00 GMT Greyster tag:iii.co.uk,2003:tst.5064867 http://www.iii.co.uk/investment/detail?code=cotn:HYG.L&display=discussion&id=5064867&action=detail Tue, 14 Jul 2009 11:13:00 GMT Greyster tag:iii.co.uk,2003:tst.3741283 See http://www.hygeavct.com/ for details of this VCT.
For what its worth one of the directors bought 35000 shares on 14 August 2007 for 30p.

TTFN

Mike
By m4hmr ]]> http://www.iii.co.uk/investment/detail?code=cotn:HYG.L&display=discussion&id=3741283&action=detail Fri, 12 Oct 2007 22:15:00 GMT m4hmr tag:iii.co.uk,2003:tst.3735654 http://www.rogueanalyst.com/2007/uncategorized/vcts-very-cheap-trusts/

thanks, Robin By tveritinov ]]> http://www.iii.co.uk/investment/detail?code=cotn:HYG.L&display=discussion&id=3735654&action=detail Wed, 10 Oct 2007 16:43:00 GMT tveritinov